MacroGenics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MacroGenics and other ETFs, options, and stocks.

About MGNX

MacroGenics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of antibody-based therapeutics for the treatment of cancer. Its product pipeline includes Margetuximab, Flotetuzumab, Retifanlimab, Enoblituzumab, Tebotelimab, MGC018, MGD019, IMGC936, and MGD014 for infectious diseases.

CEO

Scott E. Koenig

CEOScott E. Koenig

Employees

341

Employees341

Headquarters

Rockville, Maryland

HeadquartersRockville, Maryland

Founded

2000

Founded2000

Employees

341

Employees341

MGNX Key Statistics

Market cap

112.62M

Market cap112.62M

Price-Earnings ratio

-1.67

Price-Earnings ratio-1.67

Dividend yield

—

Dividend yield—

Average volume

740.04K

Average volume740.04K

High today

$1.82

High today$1.82

Low today

$1.64

Low today$1.64

Open price

$1.71

Open price$1.71

Volume

833.87K

Volume833.87K

52 Week high

$16.44

52 Week high$16.44

52 Week low

$0.9897

52 Week low$0.9897

Analyst ratings

63%

of 8 ratings

Buy

37.5%

Hold

62.5%

Sell